C4 Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | -220.9% | – | – | – | – | – | |
| – | +25.3% | +1.4% | -7.7% | +12.3% | +12.2% | -3.3% | +7.8% | |
| – | +182.1% | +109.0% | +526.8% | +39.5% | -9.3% | +8.9% | -35.6% | |
| – | +178.2% | +413.9% | +110.1% | +39.5% | – | – | – | |
| – | – | -115.5% | – | – | – | – | -482.9% | |
| – | -49.8% | -51.8% | +96.5% | +330.4% | -68.9% | -89.5% | +237.2% | |
| – | -104.4% | +11,659.6% | -0.6% | – | +171.0% | -132.4% | -83.2% | |
| – | – | – | – | – | – | – | – | |
| – | -52.4% | +546.7% | – | -62.0% | -114.2% | +76.4% | -0.5% | |
| – | +0.0% | +0.0% | -100.0% | – | – | -100.0% | – | |
| – | -87.6% | +142,904.9% | -50.9% | -99.3% | +3,865.9% | -0.3% | +178.8% | |
| – | +147.7% | +68.1% | -215.1% | – | – | -173.3% | – | |
| – | – | -225.1% | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.